Whilst the in vivo results show a clear effect, and using immunodeficient mice allows the use of human tumor cells, there is a caveat in that interfering with the PI3K pathway can influence the immune system, and examination in a syngeneic model system could be relevant. This evidence concerns the gene PIK3CD and neoplasm.